NICE approved Mounjaro for weight management (TA1026) in adults with a BMI of 35 or above with weight-related health conditions, or a BMI of 30 or above with specific comorbidities
2015;doi:10.1056/NEJMoa1411892
Rosenstock J, Frias J, Jastreboff AM et al (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
For example: People paying in cash can get Wegovy pens starting at $199 per month for the first two months and then $349 per month thereafter through Ro and NovoCare
Choose products with strains showing metabolic benefits in research rather than generic probiotic blends
For people with commercial insurance that doesnt cover weight loss medication, Eli Lilly offers Zepbound pens for $650 per month